SCHEMBL7425356

SCHEMBL7425356

CCCc1c(C(=O)O)c2ccc(C(=O)OC)cc2n1Cc1ccccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.44
TP53 P04637 3/20 0.44
DPP4 P27487 2/20 0.42
S1PR3 Q99500 2/20 0.42
RXFP1 Q9HBX9 1/20 0.40
MAPK1 P28482 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
LMNA P02545 1/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
PLA2G2A P14555 1/20 0.40
EGLN3 Q9H6Z9 1/20 0.40
SLC22A12 Q96S37 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HPGD P15428 1/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7418402 0.93 MAPT (0.43) MAPTTP53DPP4S1PR3MAPK1
SCHEMBL7425821 0.92 L3MBTL1 (0.45) MAPTTP53DPP4S1PR3MAPK1
SCHEMBL7419376 0.91 MAPT (0.43) MAPTTP53DPP4S1PR3MAPK1
SCHEMBL7419326 0.91 SLC22A12 (0.45) TP53DPP4RXFP1L3MBTL1ALDH1A1
SCHEMBL7415615 0.90 MAPT (0.43) MAPTTP53DPP4S1PR3MAPK1
SCHEMBL7425401 0.90 MAPT (0.43) MAPTTP53DPP4S1PR3MAPK1
SCHEMBL7422627 0.90 S1PR3 (0.44) MAPTTP53DPP4S1PR3RXFP1
SCHEMBL7418233 0.90 MAPT (0.42) MAPTTP53DPP4S1PR3MAPK1
SCHEMBL7422634 0.88 L3MBTL1 (0.42) MAPTTP53DPP4S1PR3MAPK1
SCHEMBL7416403 0.88 MAPT (0.41) MAPTTP53DPP4S1PR3MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed